Fox Run Management L.L.C. Invests $1.18 Million in Waters Corporation $WAT

Fox Run Management L.L.C. acquired a new position in shares of Waters Corporation (NYSE:WAT) in the 4th quarter, HoldingsChannel reports. The fund acquired 3,116 shares of the medical instruments supplier’s stock, valued at approximately $1,184,000.

Other large investors also recently modified their holdings of the company. Mondrian Investment Partners LTD acquired a new stake in shares of Waters during the 3rd quarter worth approximately $1,397,000. SG Americas Securities LLC grew its position in shares of Waters by 543.8% during the 4th quarter. SG Americas Securities LLC now owns 37,244 shares of the medical instruments supplier’s stock worth $14,146,000 after buying an additional 31,459 shares during the period. Mackenzie Financial Corp grew its position in shares of Waters by 12.2% during the 3rd quarter. Mackenzie Financial Corp now owns 231,852 shares of the medical instruments supplier’s stock worth $69,512,000 after buying an additional 25,182 shares during the period. Vanguard Group Inc. grew its position in shares of Waters by 3.3% during the 3rd quarter. Vanguard Group Inc. now owns 7,656,891 shares of the medical instruments supplier’s stock worth $2,295,612,000 after buying an additional 246,128 shares during the period. Finally, Alberta Investment Management Corp acquired a new stake in shares of Waters during the 3rd quarter worth approximately $4,677,000. Institutional investors and hedge funds own 94.01% of the company’s stock.

Insider Buying and Selling at Waters

In other news, Director Wei Jiang purchased 500 shares of the company’s stock in a transaction that occurred on Monday, March 16th. The shares were bought at an average cost of $289.46 per share, with a total value of $144,730.00. Following the completion of the transaction, the director directly owned 3,441 shares of the company’s stock, valued at approximately $996,031.86. This trade represents a 17.00% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.31% of the stock is owned by insiders.

Waters Stock Performance

NYSE WAT opened at $371.45 on Wednesday. The company has a fifty day simple moving average of $333.93 and a 200 day simple moving average of $350.57. Waters Corporation has a 12-month low of $275.05 and a 12-month high of $414.15. The company has a current ratio of 1.79, a quick ratio of 1.13 and a debt-to-equity ratio of 0.32. The company has a market cap of $36.47 billion, a P/E ratio of 47.20, a PEG ratio of 2.20 and a beta of 1.21.

Waters (NYSE:WAT) last posted its quarterly earnings results on Tuesday, May 5th. The medical instruments supplier reported $2.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.31 by $0.39. Waters had a net margin of 11.91% and a return on equity of 15.60%. The business had revenue of $1.27 billion during the quarter, compared to the consensus estimate of $1.20 billion. During the same quarter last year, the firm posted $2.25 EPS. Waters’s revenue was up 91.4% compared to the same quarter last year. Waters has set its Q2 2026 guidance at 2.950-3.050 EPS and its FY 2026 guidance at 14.400-14.600 EPS. Sell-side analysts predict that Waters Corporation will post 14.5 earnings per share for the current fiscal year.

Analysts Set New Price Targets

WAT has been the subject of several recent analyst reports. Robert W. Baird set a $387.00 price objective on shares of Waters in a research report on Wednesday, May 6th. JPMorgan Chase & Co. lifted their price target on shares of Waters from $330.00 to $345.00 and gave the company a “neutral” rating in a research report on Wednesday, May 6th. Weiss Ratings reissued a “hold (c)” rating on shares of Waters in a research report on Monday, April 20th. TD Cowen lifted their price target on shares of Waters from $345.00 to $385.00 and gave the company a “hold” rating in a research report on Wednesday, May 6th. Finally, Guggenheim reissued a “buy” rating and issued a $440.00 price target on shares of Waters in a research report on Tuesday, February 10th. Three research analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating and eight have assigned a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $394.24.

About Waters

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.